Huh? Maybe you meant to reply to the message above mine, or maybe your reading comprehension is not strong enough to understand my point. Perhaps it was a bit of both. In any event, the report is out.
No company that goeth down for a few consecutive days mayeth ever be subsequently acquired, no matter what. -Leviticus.
It is at least partially the existence of a large holder that allows for shorts to manipulate the stock. Consider that because Baupost is not trading 40% of the company, and another 40% is held by people that are not selling in the single digits no matter what, you are left with a small part of the company that actually does trade, and this creates illiquidity that manifests in violent moves up and down when the tides turn. And the tides are turning.
The tax treatment would depend upon the nature of the acquisition and how they account for it. Whether it is a cash acquisition or bought with shares could affect whether a true "sale" occurs that would trigger a gain/loss.
Rule one of looking at clinical data is to not take any free advice from Adam Feuerstein. Quite frankly, you should be wary of almost any steaming pile that TheStreet pushes out, but his are especially suspicious.
There is the risk of getting a notice to that effect if they do not file within the next 3 weeks, and then they will have about a month or two to get it in. Chances are that the quarterly report is less difficult than the annual..
Russia and Belarus have always had that ability, but you have to factor in that the entities from this geography tend to be less consistent in production and delivery than their Canadian counterparts, which is why they are able to sell the same product at a premium. It is a qualitative advantage.